person

Cristina S.

Country
Spain
Department
Oncologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
199
Sites with multiple studies

Has run more than one trial at 199 of 388 partner sites.

Specializations

Solid Tumor Oncology

Focused on advanced or metastatic solid tumors across a broad spectrum of anatomical sites.

  • Breast cancer (ER⁺/HER2‑, HER2‑positive, triple‑negative)
  • Non‑small cell lung cancer (EGFR‑mutated, KRAS‑mutated, ALK‑positive)
  • Renal cell carcinoma (clear‑cell, non‑clear‑cell)
  • Gastro‑intestinal cancers (colorectal, gastric, biliary tract, pancreatic)
  • Gynecologic malignancies (ovarian, endometrial, cervical, vulvar, anal)
  • Rare solid tumors (mesothelioma, thyroid, salivary‑gland, neuroendocrine)

Research conducted at Hospital Vall d’Hebron and its Institute of Oncology, encompassing 30 clinical trials.

Hematologic Malignancies

Investigation of high‑risk hematologic cancers and related transplant complications.

  • Acute myeloid leukemia (including IDH‑mutated and MRD‑positive disease)
  • Myelodysplastic syndromes and myeloproliferative neoplasms
  • Non‑Hodgkin lymphomas (follicular, mantle‑cell, diffuse large B‑cell, marginal‑zone)
  • Chronic lymphocytic leukemia and small‑lymphocytic lymphoma
  • Multiple myeloma (relapsed/refractory)
  • Graft‑versus‑host disease (acute and chronic forms)

Clinical programs integrate cellular therapies and targeted agents within the Vall d’Hebron oncology network.

Autoimmune and Inflammatory Disorders

Targeted studies of systemic and organ‑specific autoimmunity.

  • Systemic lupus erythematosus (including cutaneous and renal manifestations)
  • Rheumatoid arthritis and psoriatic arthritis
  • Inflammatory myopathies (dermatomyositis, immune‑mediated necrotizing myopathy)
  • Vasculitis (ANCA‑associated, IgA nephropathy)
  • Hidradenitis suppurativa
  • Atopic dermatitis

Efforts emphasize biomarker‑driven therapeutics and disease‑modifying strategies.

Infectious Diseases

Clinical evaluation of therapies for chronic and opportunistic infections.

  • Nontuberculous mycobacterial lung infection (MAC)
  • Human immunodeficiency virus infection and related complications
  • Hepatitis B and C chronic infection
  • COVID‑19 and post‑acute sequelae
  • Invasive fungal infections (aspergillosis, candidiasis)
  • Mycobacterial tuberculosis

Studies are integrated with multidisciplinary infectious disease services at the affiliated sites.

Cardiometabolic and Organ Dysfunction

Research addressing cardiovascular risk, metabolic disease, and organ‑specific failure.

  • Atherosclerotic cardiovascular disease (primary prevention and secondary care)
  • Heart failure (reduced and preserved ejection fraction)
  • Obesity and overweight with associated metabolic syndrome
  • Type 2 diabetes mellitus and diabetic complications
  • Chronic kidney disease (including transplant rejection)
  • Chronic liver disease (cirrhosis, ACLF, hepatocellular carcinoma)

Collaborative trials leverage cardiology and nephrology expertise within the Barcelona research ecosystem.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.